The future of EPAC-targeted therapies: agonism versus antagonism. (2015)
Attributed to:
The Cyclic AMP-GEF/C/EBP Pathway; a New PKA-independent Route for the Control of Gene Expression by Cyclic AMP
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.tips.2015.02.003
PubMed Identifier: 25744542
Publication URI: http://europepmc.org/abstract/MED/25744542
Type: Journal Article/Review
Volume: 36
Parent Publication: Trends in pharmacological sciences
Issue: 4
ISSN: 0165-6147